89bio
ETNB
ETNB was delisted on the 29th of October, 2025.
70 hedge funds and large institutions have $92.8M invested in 89bio in 2022 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 26 increasing their positions, 14 reducing their positions, and 23 closing their positions.
86% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 14
75.61% more ownership
Funds ownership: 83.87% → 159.48% (+76%)
44% more capital invested
Capital invested by funds: $64.3M → $92.8M (+$28.5M)
1% more funds holding
Funds holding: 69 → 70 (+1)
9% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 23
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$11.8M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$8.5M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
+$5.1M |
| 4 |
BC
Boxer Capital
San Diego,
California
|
+$4.23M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$4.23M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$6.72M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.14M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$1.58M |
| 4 |
BlackRock
New York
|
-$1.19M |
| 5 |
JP Morgan Chase
New York
|
-$356K |
ETNB Hedge Fund Activity: Q2 2022 in Review
70 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in 89bio (ETNB) for Q2 2022, worth a combined $92.8M — up 44% from $64.3M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new ETNB positions and 23 closed out — a net gain of 2 holders — while 26 added to existing stakes and 14 trimmed.
The largest buyer was BVF Inc, opening a new position worth an estimated $11.8M. The largest seller was Wellington Management Group, exiting entirely with an estimated $6.72M sold.
- 70 institutional investors held 89bio (ETNB) as of Q2 2022, up from 69 in Q1 2022.
- Funds reported $92.8M of 89bio stock for Q2 2022, up 44% quarter-over-quarter.
- 25 funds opened new 89bio positions in Q2 2022 and 23 closed out, a net change of +2 holders.
- The largest 89bio buyer in Q2 2022 was BVF Inc, an estimated $11.8M added.
- The largest 89bio seller in Q2 2022 was Wellington Management Group, an estimated $6.72M sold.
Based on aggregated 13F filings for Q2 2022.